LRP1B or TP53 mutations are associated with higher tumor mutational burden and worse survival in hepatocellular carcinoma

Conclusions: The results suggest that LRP1B or TP53 mutations are associated with higher TMB and a poor prognostic factor in HCC.

Source: Journal of Cancer - January 15, 2021 Category: Cancer & Oncology Authors: Longrong Wang, Kai Yan, Xigan He, Hongxu Zhu, Jia Song, Shiqing Chen, Shangli Cai, Yiming Zhao, Lu Wang Tags: Research Paper Source Type: research